Skip to content
Menu

Protagenic Therapeutics, Inc. PTIX

Full chart Compare
Set alert

Price alert · PTIX

All alert types
0.38 USD -0.04 (-9.52%)

As ofNov 20, 2026, 2:36 PM EST

0.3525 Day range 0.48
0.128 52-week range 2.27
YTD
-70.77%
1 year
-81.19%

 

No chart data for this range yet.
Market cap
687.88K
EPS (ttm)
2.33
Shares out
6.79M
P/E ratio
0.16
Forward P/E
-0.92
YTD return
-70.77%
1-year return
-81.19%
Volume
15.51K
Avg volume
10.61K
Open
0.4049
Previous close
0.42
Day's range
0.3525 – 0.48
52-week range
0.128 – 2.27
Beta
0.25

Key statistics

50-day average
0.6005
200-day average
0.916195
Enterprise value
1.84M
Price / book
0.65
Free cash flow
-3.12M
Total cash
924.60K
Return on equity
-206.36%
Short % of float
2.52%

Fundamental scorecard

2 of 25 checks passed on PTIX’s reported financials

ValueGrowthProfitabilityHealthDividend

2of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2025.

Financials — quick view

All financials
PTIX Revenue — quarterly 0
PTIX Net income — quarterly -869.50K
PTIX EPS — quarterly -0.47

Earnings

PTIX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.14——
Aug 14, 2024Jun 1, 20240.00-0.36——
May 15, 2024Mar 1, 20240.00-0.39——
Apr 1, 2024Dec 1, 20230.00-0.38——
Nov 14, 2023Sep 1, 20230.00-0.32——
Aug 14, 2023Jun 1, 20230.00———

About Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on PTIX — it syncs with the Stock Master app.

Insider holders

PTIX insider holders
InsiderRelationLatest transactionDateShares held
ARROW ALEXANDER KChief Financial OfficerPurchaseOct 11, 202345,815

Institution ownership

PTIX institution ownership
Holder% heldSharesValueReported
Citadel Advisors Llc0.57%40,90921.87KSep 29, 2024
Vanguard Group Inc0.46%33,16617.73KSep 29, 2024
Geode Capital Management, LLC0.36%26,05413.93KSep 29, 2024
Osaic Holdings Inc0.30%21,41411.45KSep 29, 2024
State Street Corporation0.19%13,8127.38KSep 29, 2024
Virtu Financial LLC0.18%13,1187.01KSep 29, 2024

Fund ownership

PTIX fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.45%31,99617.11KSep 29, 2024
Fidelity Extended Market Index Fund0.24%17,0599.12KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.07%5,0072.68KOct 30, 2024
Fidelity Series Total Market Index Fund0.05%3,2891.76KOct 30, 2024